Moomoo 24/7 ·  Feb 29 08:06
SELLAS Life Sciences To Present SLS009 Phase 1 Data From Acute Myeloid Leukemia Patients At 2024 ESH Conference
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment